益肝清毒颗粒与恩替卡韦胶囊联合应用治疗慢性乙型肝炎有效性和安全性的随机双盲平行对照多中心Ⅱ期临床研究
[Translation] A randomized, double-blind, parallel-controlled, multicenter phase II clinical study on the efficacy and safety of Yiganqingdu granules combined with entecavir capsules in the treatment of chronic hepatitis B
1.探索益肝清毒颗粒与恩替卡韦胶囊联合应用治疗慢性乙型肝炎肝胆湿热兼肝郁血瘀证的抗病毒作用。 2.探索益肝清毒颗粒与恩替卡韦胶囊联合应用对于慢性乙型肝炎的证候改善作用。 3.观察益肝清毒颗粒临床应用的安全性。
[Translation] 1. To explore the antiviral effect of Yiganqingdu granules combined with entecavir capsules in the treatment of chronic hepatitis B with liver-gallbladder damp-heat and liver depression and blood stasis. 2. To explore the effect of Yiganqingdu granules combined with entecavir capsules on improving the symptoms of chronic hepatitis B. 3. To observe the safety of Yiganqingdu granules in clinical application.
区组随机、双盲、安慰剂平行对照评价经痛平胶囊治疗痛经寒凝血瘀证有效性和安全性的多中心临床研究
[Translation] A multicenter clinical study using randomized controlled, double-blind, placebo-controlled methods to evaluate the efficacy and safety of Jingtongping capsules in the treatment of dysmenorrhea with cold coagulation and blood stasis syndrome
[Translation] Confirm the effectiveness and safety of Jingtongping Capsule in treating dysmenorrhea with cold coagulation and blood stasis syndrome
100 Clinical Results associated with Beijing Rongzhiyuan Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Beijing Rongzhiyuan Pharmaceutical Technology Co., Ltd.
100 Deals associated with Beijing Rongzhiyuan Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Beijing Rongzhiyuan Pharmaceutical Technology Co., Ltd.